Arteris director sells 20,000 shares via trust
Arteris, Inc. director Antonio J. Viana, through the Viana Family Trust, sold 20,000 shares of Arteris common stock in an open-market transaction at a weighted average price of $26.1117 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Arteris, Inc. director Antonio J. Viana, through the Viana Family Trust, sold 20,000 shares of Arteris common stock in an open-market transaction at a weighted average price of $26.1117 per share. After the sale, the trust held 124,620 shares indirectly, and Viana held 20,840 shares directly. The sale was executed under a Rule 10b5-1 trading plan adopted on June 10, 2025.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 20,000 | $26.1117 | $522K |
| holding | Common Stock | -- | -- | -- |
Footnotes (2)
- F1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on June 10, 2025.
- F2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.35 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average sale price financial
open-market sale financial
indirect ownership financial
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Arteris (AIP) director Antonio J. Viana do in this Form 4 filing?
Was the Arteris (AIP) insider sale made under a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.